Human anaplastic thyroid cancer cells (KAT-18) express MET and the opioid growth factor receptor; MET blocked cell replication, the opioid antagonist naltrexone promoted cell growth, and anti-MET antibodies counteracted the inhibitory action mediated by MET [289]. The gene discussed is MET; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.